Alexion Pharmaceuticals, Inc.

BALYASNY ASSET MANAGEMENT L.P. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/16/2021

Shares

771,620

Value ($000)

141,754

Weight

0.8%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/16/2021	141,754	0.8%	771,620	6/30/2021
2021 Q1	5/17/2021	122,381	0.7%	800,344	3/31/2021
2020 Q4	2/16/2021	51,528	0.3%	329,802	12/31/2020
2020 Q3	11/16/2020	36,163	0.3%	316,028	9/30/2020
2020 Q2	8/14/2020	16,446	0.2%	146,522	6/30/2020
2020 Q1	5/15/2020	8,640	0.1%	96,219	3/31/2020
2019 Q4	2/14/2020	34,229	0.2%	316,499	12/31/2019